The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence
Open accessAbstract
Opioid use for long-term pain management is limited by adverse side effects, such as hyperalgesia and negative affect. Neuroinflammation in the brain and spinal cord is a contributing factor to the development of symptoms associated with chronic opioid use. Recent studies have described a link between neuroinflammation and behavior that is mediated by a gut-brain signaling axis, where alterations in indigenous gut bacteria contribute to several inflammation-related psychopathologies. As opioid receptors are highly expressed within the digestive tract and opioids influence gut motility, we hypothesized that systemic opioid treatment will impact the composition of the gut microbiota. Here, we explored how opioid treatments, and cessation, impacts the mouse gut microbiome and whether opioid-induced changes in the gut microbiota influences inflammation-driven hyperalgesia and impaired reward behavior. Male C57Bl6/J mice were treated with either intermittent or sustained morphine. Using 16S rDNA sequencing, we describe changes in gut microbiota composition following different morphine regimens. Manipulation of the gut microbiome was used to assess the causal relationship between the gut microbiome and opioid-dependent behaviors. Intermittent, but not sustained, morphine treatment was associated with microglial activation, hyperalgesia, and impaired reward response. Depletion of the gut microbiota via antibiotic treatment surprisingly recapitulated neuroinflammation and sequelae, including reduced opioid analgesic potency and impaired cocaine reward following intermittent morphine treatment. Colonization of antibiotic-treated mice with a control microbiota restored microglial activation state and behaviors. Our findings suggest that differing opioid regimens uniquely influence the gut microbiome that is causally related to behaviors associated with opioid dependence.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Vitamin and mineral deficiencies associated with opioid addiction have been well-described.
“Vitamin and mineral deficiencies associated with opioid addiction have been well-described (160–165).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [163]
Antibiotic-treated rodents transplanted with saline microbiota have restored reward functioning.
“However, it has been shown that antibiotic-treated rodents transplanted with saline microbiota have restored reward functioning (163).”
From A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health (2019) · cites this paper as [163]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Lozupone, C., Turnbaugh, P. J., Fierer, N., & Knight, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000080107 · Cited by 9,633 · see citing works
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · see citing works
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569 · see citing works
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735 · see citing works
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023 · see citing works
Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748 · see citing works
Gut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503 · see citing works
Principles and clinical implications of the brain-gut-enteric microbiota axis
Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.35 · Cited by 1,342 · see citing works
Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring
Buffington, S. A., Di Prisco, G. V., Auchtung, T. A., Ajami, N. J., Petrosino, J. F., & Costa-Mattioli, M. (2016) · Cell · doi:10.1016/j.cell.2016.06.001 · Cited by 1,163 · see citing works
Stress & the gut-brain axis: Regulation by the microbiome
Foster, J. A., Rinaman, L., & Cryan, J. F. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2017.03.001 · Cited by 1,150 · see citing works
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110 · see citing works
Dopamine neurons modulate neural encoding and expression of depression-related behaviour
Tye, K. M., Mirzabekov, J. J., Warden, M. R., Ferenczi, E. A., Tsai, H.-C., Finkelstein, J., Kim, S.-Y., Adhikari, A., Thompson, K. R., Andalman, A. S., et al. (2013) · Nature · doi:10.1038/nature11740 · Cited by 1,073 · see citing works
Fröhlich, E. E., Farzi, A., Mayerhofer, R., Reichmann, F., Jačan, A., Wagner, B., Zinser, E., Bordag, N., Magnes, C., Fröhlich, E., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.02.020 · Cited by 720 · see citing works
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
Hutchinson, M. R., Zhang, Y., Shridhar, M., Evans, J. H., Buchanan, M. M., Zhao, T. X., Slivka, P. F., Coats, B. D., Rezvani, N., Wieseler, J. L., et al. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.08.004 · Cited by 575 · see citing works
Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa and Epithelial Gene Expression
Reikvam, D. H., Erofeev, A. S., Sandvik, A., Grcic, V., Jahnsen, F. L., Gaustad, P., McCoy, K. D., Macpherson, A. J., Meza‐Zepeda, L. A., & Johansen, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017996 · Cited by 531 · see citing works
Tynan, R. J., Naicker, S., Hinwood, M., Nalivaiko, E., Buller, K. M., Pow, D. V., Day, T. A., & Walker, F. R. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.02.001 · Cited by 531 · see citing works
Quantitating the subtleties of microglial morphology with fractal analysis
Karperien, A., Ahammer, H., & Jelinek, H. F. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00003 · Cited by 517 · see citing works
Vasudeva, R., Rutkowski, M. D., & DeLeo, J. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09980.2002 · Cited by 468 · see citing works
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 453 · see citing works
The involvement of glial cells in the development of morphine tolerance
Song, P., & Zhao, Z.-Q. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(00)00226-1 · Cited by 445 · see citing works
Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl− homeostasis
Ferrini, F., Trang, T., Mattioli, T.-A. M., Laffray, S., Del’Guidice, T., Lorenzo, L.-É., Castonguay, A., Doyon, N., Zhang, W., Godin, A. G., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3295 · Cited by 441 · see citing works
Clinical Pharmacokinetics of Vancomycin
Matzke, G. R., Zhanel, G. G., & Guay, D. R. P. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611040-00001 · Cited by 360 · see citing works
Neural substrates of opiate withdrawal
Koob, G. F., Maldonado, R. J., & Stinus, L. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90171-4 · Cited by 356 · see citing works
Corder, G. F., Tawfik, V. L., Wang, D., Sypek, E. I., Low, S. A., Dickinson, J. R., Sotoudeh, C., Clark, J. D., Barres, B. A., Bohlen, C. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4262 · Cited by 347 · see citing works
LYTE, M., LI, W., OPITZ, N., GAYKEMA, R., & GOEHLER, L. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.06.019 · Cited by 334 · see citing works
Hutchinson, M. R., Lewis, S. S., Coats, B. D., Skyba, D. A., Crysdale, N. Y., Berkelhammer, D. L., Brzeski, A., Northcutt, A. L., Vietz, C. M., Judd, C. M., et al. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.09.012 · Cited by 301 · see citing works
Yarandi, S., Peterson, D. A., Treisman, G. J., Moran, T. H., & Pasricha, P. J. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15146 · Cited by 294 · see citing works
Goehler, L. E., Park, S. M., Opitz, N., Lyte, M., & Gaykema, R. P. A. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.08.009 · Cited by 287 · see citing works
Opioid activation of Toll-Like receptor 4 contributes to drug reinforcement
Hutchinson, M., Northcutt, A., Hiranita, T., Wang, X.-H., Lewis, S. S., Thomas, J., van Steeg, K., Kopajtic, T., Loram, L., Sfregola, C., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0684-12.2012 · Cited by 279 · see citing works
Banerjee, S., Sindberg, G., Wang, F., Meng, J., Sharma, U., Zhang, L., Dauer, P., Chen, C., Dalluge, J., Johnson, T., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.9 · Cited by 266 · see citing works
Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine
Kiraly, D. D., Walker, D. M., Calipari, E. S., Labonté, B., Issler, O., Peña, C. J., Ribeiro, E., Russo, S. J., & Nestler, E. J. (2016) · Scientific Reports · doi:10.1038/srep35455 · Cited by 264 · see citing works
Raghavendra, V., Tanga, F. Y., & DeLeo, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300315 · Cited by 263 · see citing works
Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model
Wang, F., Meng, J., Zhang, L., Johnson, T., Chen, C., & Roy, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21915-8 · Cited by 238 · see citing works
Thomsen, K. R., Whybrow, P. C., & Kringelbach, M. L. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00049 · Cited by 235 · see citing works
Opioids and the gut: pharmacology and current clinical experience
Schepper, H. U. D., Cremonini, F., Park, M., & Camilleri, M. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00513.x · Cited by 214 · see citing works
Meng, J., Yu, H., Ma, J., Wang, J., Banerjee, S., Charboneau, R., Barke, R. A., & Roy, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054040 · Cited by 212 · see citing works
Acharya, C., Betrapally, N. S., Gillevet, P. M., Sterling, R. K., Akbarali, H., White, M. B., Ganapathy, D., Fagan, A., Sikaroodi, M., & Bajaj, J. S. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13858 · Cited by 175 · see citing works
Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents
Burma, N. E., Bonin, R. P., Leduc‐Pessah, H., Baimel, C., Cairncross, Z. F., Mousseau, M., Shankara, J. V., Stemkowski, P. L., Baimoukhametova, D. V., Bains, J. S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4281 · Cited by 154 · see citing works
The effect of gut microbiome on tolerance to morphine mediated antinociception in mice
Kang, M., Mischel, R. A., Bhave, S., Komla, E., Cho, A., Huang, C., Dewey, W. L., & Akbarali, H. I. (2017) · Scientific Reports · doi:10.1038/srep42658 · Cited by 154 · see citing works
Neurobiology of opioid dependence in creating addiction vulnerability
Evans, C. J., & Cahill, C. M. (2016) · F1000Research · doi:10.12688/f1000research.8369.1 · Cited by 146 · see citing works
Allostatic mechanisms of opioid tolerance beyond desensitization and downregulation
Cahill, C. M., Walwyn, W., Taylor, A. M. W., Pradhan, A. A. A., & Evans, C. J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.08.002 · Cited by 122 · see citing works
Taylor, A. M. W., Castonguay, A., Ghogha, A., Vayssiere, P., Pradhan, A. A. A., Xue, L., Mehrabani, S., Wu, J., Levitt, P., Olmstead, M. C., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.221 · Cited by 109 · see citing works
Self-citationGutsy Moves: The Amygdala as a Critical Node in Microbiota to Brain Signaling
Cowan, C. S. M., Hoban, A. E., Ventura‐Silva, A. P., Dinan, T. G., Clarke, G. A., & Cryan, J. F. (2017) · BioEssays · doi:10.1002/bies.201700172 · Cited by 107 · see citing works
Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis
Nee, J. W., Zakari, M., Sugarman, M. A., Whelan, J., Hirsch, W., Sultan, S., Ballou, S., Iturrino, J., & Lembo, A. J. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.021 · Cited by 91 · see citing works
Neuroinflammation—a co-occurring phenomenon linking chronic pain and opioid dependence
Cahill, C. M., & Taylor, A. M. W. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.12.003 · Cited by 82 · see citing works
Leri, F., Zhou, Y., Goddard, B., Cummins, E., & Kreek, M. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300927 · Cited by 59 · see citing works
Safety concerns with long-term opioid use
Harned, M. E., & Sloan, P. A. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1177509 · Cited by 48 · see citing works
Bhave, S. M., Gade, A. R., Kang, M., Hauser, K. F., Dewey, W. L., & Akbarali, H. I. (2017) · The FASEB Journal · doi:10.1096/fj.201601068r · Cited by 48 · see citing works
Zhou, Y., Leri, F., Ho, A., & Kreek, M. J. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1091-3 · Cited by 25 · see citing works
Laorden, E. M., Hurlé, M. A., Milanés, M. V., Laorden, M. L., & Almela, P. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.193581 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · see citing works
Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential
Guo, R., Chen, L., Xing, C., & Liu, T. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.07.026 · Cited by 416 · see citing works
Matson, V., Chervin, C. S., & Gajewski, T. F. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.11.041 · Cited by 385 · see citing works
Psychotropics and the Microbiome: a Chamber of Secrets…
Cussotto, S., Clarke, G. A., Dinan, T. G., & Cryan, J. F. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5185-8 · Cited by 169 · see citing works
Zhang, L., Meng, J., Ban, Y. J., Jalodia, R., Chupikova, I., Fernández, I., Brito, N., Sharma, U., Abreu, M. T., Ramakrishnan, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901182116 · Cited by 160 · see citing works
Microbiota‐gut‐brain axis as a regulator of reward processes
García‐Cabrerizo, R., Carbia, C., O’Riordan, K. J., Schellekens, H., & Cryan, J. F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15284 · Cited by 147 · see citing works
A potential role for the gut microbiome in substance use disorders
Meckel, K. R., & Kiraly, D. D. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05232-0 · Cited by 141 · see citing works
Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study
Fan, J., Zhou, Y., Meng, R., Tang, J., Zhu, J., Aldrich, M. C., Cox, N. J., Zhu, Y., Li, Y., & Zhou, D. (2023) · BMC Medicine · doi:10.1186/s12916-023-02863-1 · Cited by 121 · see citing works
Oxycodone in the Opioid Epidemic: High ‘Liking’, ‘Wanting’, and Abuse Liability
Kibaly, C., Alderete, J. A., Liu, S. H., Nasef, H., Law, P., Evans, C. J., & Cahill, C. M. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01013-y · Cited by 116 · see citing works
An affective neuroscience model of boosting resilience in adults
Tabibnia, G. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.005 · Cited by 109 · see citing works
Zádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 90 · see citing works
Ma, Y., Liu, S., Shu, H., Crawford, J. A., Xing, Y., & Tao, F. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.016 · Cited by 83 · see citing works
A biological framework for emotional dysregulation in alcohol misuse: from gut to brain
Carbia, C., Lannoy, S., Maurage, P., López‐Caneda, E., O’Riordan, K. J., Dinan, T. G., & Cryan, J. F. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00970-6 · Cited by 80 · see citing works
Cuesta, S., Burdisso, P., Segev, A., Kourrich, S., & Sperandio, V. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.09.014 · Cited by 75 · see citing works
Gut Microbiome in Anesthesiology and Pain Medicine
Minerbi, A., & Shen, S. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004204 · Cited by 73 · see citing works
Lefevre, E. M., Pisansky, M. T., Toddes, C., Baruffaldi, F., Pravetoni, M., Tian, L., Kono, T. J. Y., & Rothwell, P. E. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0643-x · Cited by 69 · see citing works
The role of the gut microbiome in opioid use
Ren, M., & Lotfipour, S. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000538 · Cited by 68 · see citing works
Hofford, R. S., Mervosh, N. L., Euston, T. J., Meckel, K. R., Orr, A. T., & Kiraly, D. D. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01043-0 · Cited by 64 · see citing works
The Gut Microbiome in Schizophrenia and the Potential Benefits of Prebiotic and Probiotic Treatment
Liu, J. C. W., Gorbovskaya, I., Hahn, M., & Müller, D. J. (2021) · Nutrients · doi:10.3390/nu13041152 · Cited by 65 · see citing works
Opioid system influences gut-brain axis: Dysbiosis and related alterations
Rueda‐Ruzafa, L., Cruz, F., Cardona, D., Hone, A. J., Molina‐Torres, G., Sánchez‐Labraca, N., & Román, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104928 · Cited by 64 · see citing works
Simpson, S., Kimbrough, A., Boomhower, B., Mclellan, R., Hughes, M., Shankar, K., de Guglielmo, G., & George, O. (2020) · eNeuro · doi:10.1523/eneuro.0312-19.2020 · Cited by 61 · see citing works
Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders
Simpson, S., Mclellan, R., Wellmeyer, E., Matalon, F., & George, O. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10022-7 · Cited by 61 · see citing works
Hong, H., Xu, L., Lu, Q., Huang, C., & Cui, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015035 · Cited by 60 · see citing works
Liao, K., Niu, F., Hu, G., Yang, L., Dallon, B. W., Villarreal, D. J., & Buch, S. J. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12027 · Cited by 57 · see citing works
Kolli, U., Jalodia, R., Moidunny, S., Singh, P. K., Ban, Y. J., Tao, J., Cantu, G. N., Valdes, E., Ramakrishnan, S., & Roy, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2246184 · Cited by 59 · see citing works
Cook, R., Fulcher, J. A., Tobin, N. H., Li, F., Lee, D., Woodward, C. L., Javanbakht, M., Brookmeyer, R., SHOPTAW, S. J., Bolan, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51142-8 · Cited by 55 · see citing works
Hakimian, J. K., Dong, T. S., Barahona, J. A., Lagishetty, V., Tiwari, S., Azani, D., Barrera, M., Lee, S., Severino, A. L., Mittal, N., et al. (2019) · Nutrients · doi:10.3390/nu11081900 · Cited by 51 · see citing works
Role of gut microbiota in neuropathy and neuropathic pain states: A systematic preclinical review
Pane, K., Boccella, S., Guida, F., Franzese, M., Maione, S., & Salvatore, M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105773 · Cited by 52 · see citing works
Thomaz, A. C., Iyer, V., Woodward, T. J., & Hohmann, A. G. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113787 · Cited by 46 · see citing works
Manipulation of Gut Microbiota as a Key Target for Crohn's Disease
Rashed, R. T., Valcheva, R. S., & Dieleman, L. A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.887044 · Cited by 49 · see citing works
Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight
Angoa‐Pérez, M., & Kuhn, D. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000144 · Cited by 44 · see citing works
Microbiome and substances of abuse
Salavrakos, M., Leclercq, S., de Timary, P., & Dom, G. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110113 · Cited by 43 · see citing works
Yang, C., Fu, X., Hao, W., Xiang, X., Liu, T., Yang, B., & Zhang, X. (2020) · Addiction Biology · doi:10.1111/adb.12975 · Cited by 43 · see citing works
A Biopsychosocial Overview of the Opioid Crisis: Considering Nutrition and Gastrointestinal Health
Wiss, D. A. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00193 · Cited by 41 · see citing works
Angoa‐Pérez, M., Zagorac, B., Winters, A. D., Greenberg, J. M., Ahmad, M. M., Theis, K. R., & Kuhn, D. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227774 · Cited by 40 · see citing works
The Gut Microbiome and Substance Use Disorder
Russell, J. T., Zhou, Y., Weinstock, G. M., & Bubier, J. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.725500 · Cited by 40 · see citing works
Hawkins, K. G., Casolaro, T. C., Brown, J. A., Edwards, D. A., & Wikswo, J. P. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1870 · Cited by 34 · see citing works
Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System
Jalodia, R., Abu, Y. F., Oppenheimer, M. R., Truitt, B., Meng, J., Chupikova, I., Tao, J., Ghosh, N., Dutta, R. K., Kolli, U., et al. (2022) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10046-z · Cited by 35 · see citing works
Gut-derived bacterial LPS attenuates incubation of methamphetamine craving via modulating microglia
Yu, Z., Chen, W., Zhang, L., Chen, Y., Chen, W., Meng, S., Lü, L., Han, Y., & Shi, J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.027 · Cited by 34 · see citing works
Meckel, K. R., Simpson, S., Godino, A., Peck, E. G., Sens, J. P., Leonard, M. Z., George, O., Calipari, E. S., Hofford, R. S., & Kiraly, D. D. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01661-w · Cited by 34 · see citing works
Zhang, J., Deji, C., Fan, J., Chang, L., Miao, X., Xiao, Y., Zhu, Y., & Li, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110058 · Cited by 34 · see citing works
Chen, Z., Lin, Y., Zhou, Q., Shilin, X., Li, C., Lin, R., Li, J., Chen, Y., Luo, C., & Mo, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112935 · Cited by 33 · see citing works
Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse
Han, Y., Cao, L., Yuan, K., Shi, J., Yan, W., & Lü, L. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00872-3 · Cited by 32 · see citing works
Abu, Y. F., Singh, S., Tao, J., Chupikova, I., Singh, P. K., Meng, J., & Roy, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2292224 · Cited by 32 · see citing works
On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance
Fürst, S., Zádori, Z., Zádor, F., Király, K. P., Balogh, M., László, S. B., Hutka, B., Mohammadzadeh, A., Calabrese, C., Galambos, A. R., et al. (2020) · Molecules · doi:10.3390/molecules25112473 · Cited by 31 · see citing works
A gut (microbiome) feeling about addiction: Interactions with stress and social systems
García‐Cabrerizo, R., & Cryan, J. F. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100629 · Cited by 30 · see citing works
Lucerne, K. E., Osman, A., Meckel, K. R., & Kiraly, D. D. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108598 · Cited by 26 · see citing works
Grecco, G. G., Gao, Y., Gao, H., Liu, Y., & Atwood, B. K. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108914 · Cited by 28 · see citing works
Abu, Y. F., Tao, J., Dutta, R. K., Yan, Y., Vitari, N., Kolli, U., & Roy, S. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10019-2 · Cited by 28 · see citing works
The Microbiome–Gut–Brain Axis, a Potential Therapeutic Target for Substance-Related Disorders
Fu, X., Chen, T., Cai, J., Liu, B., Zeng, Y., & Zhang, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.738401 · Cited by 28 · see citing works
Zhang, J., Yang, J., Yang, C., Chen, T., Wang, Z., Li, J., Qin, F., Deng, Q., & Zhang, X. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00631 · Cited by 27 · see citing works
Ren, M., & Lotfipour, S. (2022) · Microorganisms · doi:10.3390/microorganisms10061127 · Cited by 27 · see citing works
Substance use, microbiome and psychiatric disorders
Chivero, E. T., Sil, S., Kumar, M., & Buch, S. J. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173432 · Cited by 24 · see citing works
Hofford, R. S., Meckel, K. R., Wiser, E. J., Wang, W., Sens, J. P., Kim, M., Godino, A., Lam, T. T., & Kiraly, D. D. (2023) · eNeuro · doi:10.1523/eneuro.0388-23.2023 · Cited by 24 · see citing works
Considering the Microbiome in Stress-Related and Neurodevelopmental Trajectories to Schizophrenia
Hoffman, K. W., Lee, J. J., Corcoran, C. M., Kimhy, D., Kranz, T. M., & Malaspina, D. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00629 · Cited by 23 · see citing works
Endogenous Opiates and Behavior: 2018
Bodnar, R. J. (2020) · Peptides · doi:10.1016/j.peptides.2020.170348 · Cited by 22 · see citing works
Komla, E., Stevens, D. L., Zheng, Y., Zhang, Y., Dewey, W. L., & Akbarali, H. I. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256941 · Cited by 22 · see citing works
García‐Cabrerizo, R., Barros-Santos, T., Campos, D., & Cryan, J. F. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.020 · Cited by 21 · see citing works
Clinical and Preclinical Evidence for Gut Microbiome Mechanisms in Substance Use Disorders
Hofford, R. S., & Kiraly, D. D. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.08.004 · Cited by 19 · see citing works
Gut microbiome associated dysbiosis: Limited regimens and expanding horizons of phage therapy
Singha, B., Rawat, B. S., Venkataraman, R., Nair, T., Rosenn, E. H., & Soni, V. (2023) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2023.100029 · Cited by 22 · see citing works
Role of microbes in the pathogenesis of neuropsychiatric disorders
Goswami, A., Wendt, F. R., Pathak, G. A., Tylee, D. S., Angelis, F. D., Lillo, A. D., & Polimanti, R. A. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100917 · Cited by 20 · see citing works
Yang, Y. X., Xu, Z., Guo, J., Xiong, Z., & Hu, B. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100763 · Cited by 20 · see citing works
The Impact of Alcohol-Induced Dysbiosis on Diseases and Disorders of the Central Nervous System
Liu, X., Vigorito, M., Huang, W., Khan, M. A. S., & Chang, S. L. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10033-4 · Cited by 19 · see citing works
Ren, M., & Lotfipour, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010409 · Cited by 17 · see citing works
Clinical neuroscience of addiction: what clinical psychologists need to know and why
Ray, L. A., & Grodin, E. N. (2021) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081219-114309 · Cited by 18 · see citing works
Gut Microbiota‐Derived Extracellular Vesicles Influence Alcohol Intake Preferences in Rats
Díaz‐Ubilla, M., Figueroa‐Valdés, A. I., Tobar, H. E., Quintanilla, M. E., Díaz, E., Morales, P., Berríos‐Cárcamo, P., Santapau, D., Gallardo, J., Gregorio, C. D., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70059 · Cited by 18 · see citing works
Wang, Y., Zhang, J., Deji, C., Fan, J., Miao, X., Li, S. C., Zeng, X., & Guan, F. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24963 · Cited by 18 · see citing works
Wang, Y., Wang, M., Xie, B., Wen, D., Li, W., Zhou, M., Wang, X., Lu, Y., Cong, B., Ni, Z., et al. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.12.003 · Cited by 18 · see citing works
Essmat, N., Karádi, D. Á., Zádor, F., Király, K. P., Fürst, S., & Al‐Khrasani, M. (2023) · Molecules · doi:10.3390/molecules28237766 · Cited by 18 · see citing works
Opioid Modulation of the Gut–Brain Axis in Opioid-Associated ComorbiditiesPreprint
Zhang, L., & Roy, S. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a040485 · Cited by 18 · see citing works
Endogenous opiates and behavior: 2019
Bodnar, R. J. (2021) · Peptides · doi:10.1016/j.peptides.2021.170547 · Cited by 17 · see citing works
Wang, Q., Guo, X., Yue, Q., Zhu, S., Guo, L., Li, G., Zhou, Q., Xiang, Y., Chen, G., Yin, W., et al. (2022) · The Anatomical Record · doi:10.1002/ar.25055 · Cited by 17 · see citing works
The Microbiome and Mental Health Across the Lifespan
Dickerson, F., Dilmore, A. H., Godoy‐Vitorino, F., Nguyen, T. T., Paulus, M. P., Pinto‐Tomás, A. A., Moya-Roman, C., Zúñiga-Chaves, I., Severance, E. G., & Jeste, D. V. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_384 · Cited by 17 · see citing works
Li, X., Song, G.-F., Yu, J., Ai, S.-H., Ji, Q., Peng, Y., Zhu, X., & Liu, J.-G. (2021) · Medicine · doi:10.1097/md.0000000000025208 · Cited by 16 · see citing works
Gerace, E., Baldi, S., Salimova, M., Gloria, L. D., Curini, L., Cimino, V., Nannini, G., Russo, E., Pallecchi, M., Ramazzotti, M., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106627 · Cited by 16 · see citing works
Sens, J. P., Hofford, R. S., & Kiraly, D. D. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103874 · Cited by 15 · see citing works
Barkus, A., Baltrūnienė, V., Baušienė, J., Baltrūnas, T., Barkienė, L., Kazlauskaitė, P., & Baušys, A. (2024) · Life · doi:10.3390/life14101227 · Cited by 17 · see citing works
The Central Role of Gut Microbiota in Drug Metabolism and Personalized Medicine
Colotti, G., & Rinaldi, T. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0023 · Cited by 16 · see citing works
The role of gut-immune-brain signaling in substance use disorders
Lucerne, K. E., & Kiraly, D. D. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.005 · Cited by 16 · see citing works
Mental Disorders Linked to Crosstalk between The Gut Microbiome and The Brain
Choi, T.-Y., Choi, Y. P., & Koo, J. W. (2020) · Experimental Neurobiology · doi:10.5607/en20047 · Cited by 17 · see citing works
Kazemian, N., & Pakpour, S. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.70030 · Cited by 15 · see citing works
Pharmacogenomic and Pharmacomicrobiomic Aspects of Drugs of Abuse
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Genes · doi:10.3390/genes16040403 · Cited by 15 · see citing works
The roles of the circadian hormone melatonin in drug addiction
Jia, S., Guo, X., Chen, Z., Li, S., & Liu, X.-A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106371 · Cited by 14 · see citing works
Lewin‐Epstein, O., Jaques, Y., Feldman, M. W., Kaufer, D., & Hadany, L. (2023) · Communications Biology · doi:10.1038/s42003-023-05099-0 · Cited by 12 · see citing works
Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease
Parker, K. E., Sugiarto, E., Taylor, A. M. W., Pradhan, A. A. A., & Al‐Hasani, R. (2020) · Molecular Pharmacology · doi:10.1124/mol.120.119438 · Cited by 13 · see citing works
Potential Role of Host Microbiome in Areca Nut-Associated Carcinogenesis and Addiction
Chen, L., Yuan, F., Chen, S., Li, X., Kong, L., & Zhang, W. (2022) · Molecules · doi:10.3390/molecules27238171 · Cited by 13 · see citing works
Opioid Use and Gut Dysbiosis in Cancer Pain Patients
Coluzzi, F., Scerpa, M. S., Loffredo, C., Borro, M., Pergolizzi, J. V., LeQuang, J. A., Alessandri, E., Simmaco, M., & Rocco, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147999 · Cited by 12 · see citing works
Lin, L., Lin, J., Qiu, J., Feng, W., Bai, X., Ma, W., Zeng, J., & Lin, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.994170 · Cited by 12 · see citing works
The interplay between the microbiota and opioid in the treatment of neuropathic pain
Gong, Z., Xue, Q., Luo, Y., Yu, B., Hua, B., & Liu, Z. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1390046 · Cited by 11 · see citing works
Mischel, R. A., Muchhala, K. H., Dewey, W. L., & Akbarali, H. I. (2019) · Journal of Pain · doi:10.1016/j.jpain.2019.11.015 · Cited by 10 · see citing works
Freedman, Z. G., Kane, J. A., King, T. S., & Graziane, N. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.1926889 · Cited by 11 · see citing works
The future of neuroimaging and gut-brain axis research for substance use disorders
Colón-Pérez, L. M., Montesinos, J. S., & Monsivais, M. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147835 · Cited by 11 · see citing works
The Gut Microbiota-Brain Axis: Potential Mechanism of Drug Addiction
Luo, X., Li, H., Fan, X., Wu, X., Zhou, R.-Y., Lei, Y., Xue, D., Yang, F., Xu, Y., & Wang, K. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230418114133 · Cited by 11 · see citing works
Lakosa, A., Rahimian, A., Tomasi, F., Marti, F., Reynolds, L. M., Tochon, L., David, V., Danckaert, A., Canonne, C., Tahraoui, S., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01563-x · Cited by 10 · see citing works
From bugs to behavior: targeting the gut-brain interface for addiction therapeutics
Ru, Y., Jia, J., Yang, X., Ba, X., Yan, J., Zhang, H., & Zhang, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2569740 · Cited by 10 · see citing works
Sall, I., Foxall, R. L., Felth, L. C., Maret, S., Rosa, Z., Gaur, A., Calawa, J., Pavlik, N., Whistler, J. L., & Whistler, C. A. (2025) · Gut Microbes · doi:10.1080/19490976.2024.2446423 · Cited by 10 · see citing works
Gut-Microbiome Implications in Opioid Use Disorder and Related Behaviors
Herlihy, B., & Roy, S. (2022) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2022.10311 · Cited by 10 · see citing works
Harder, H. J., Gomez, M. G., Searles, C. T., Vogt, M. E., & Murphy, A. Z. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.01.019 · Cited by 9 · see citing works
Potential roles of the gut microbiota in the manifestations of drug use disorders
Wang, Z., Hou, C., Chen, L., Zhang, M., & Luo, W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1046804 · Cited by 9 · see citing works
Puig, S., & Gutstein, H. B. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.03.025 · Cited by 9 · see citing works
- Authors
- Lee, K., Vuong, H. E., Nusbaum, D. J., Hsiao, E. Y., Evans, C. J., & Taylor, A. M. W.
- Affiliations
- University of California, Los Angeles (US)
- University of Alberta (CA)
- Corresponding author
- Taylor, Anna M. W.
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2018-09-10
- Volume
- 43
- Issue
- 13
- Pages
- 2606-2614
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC6224506
- OpenAlex
- W2890990778
- Cited by
- 172
- References
- 50
- Citations by year
- 2026: 6 · 2025: 19 · 2024: 19 · 2023: 26 · 2022: 34 · 2021: 26 · 2020: 26 · 2019: 15 · 2018: 1
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alfred P. Sloan Foundation
- American Pain Society
- National Institute of Mental Health (F31MH090749)
- National Institute on Drug Abuse (P50DA005010, DA 005010, K99DA040016)
- National Institute of General Medical Sciences (K12GM106996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- gut microbiota, morphine dependence, opioid use disorder, neuroinflammation, microglial activation, hyperalgesia, opioid reward, cocaine reward, gut-brain axis, antibiotic-induced microbiota depletion, chronic opioid use
- MeSH terms
- Gastrointestinal Microbiome, Analgesics, Opioid, Animals, Intestinal Absorption, Male, Mice, Inbred C57BL, Morphine, Morphine Dependence, Reward, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review